Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
about
Confronting the neglected problem of snake bite envenoming: the need for a global partnershipNatural Inhibitors of Snake Venom Metalloendopeptidases: History and Current ChallengesEffects of Bothrops asper snake venom on lymphatic vessels: insights into a hidden aspect of envenomationAntivenom for Neuromuscular Paralysis Resulting From Snake Envenoming.Treatments for Latrodectism-A Systematic Review on Their Clinical Effectiveness.Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges AheadNeurological complications of venomous snake bites: a review.Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.Current treatment for venom-induced consumption coagulopathy resulting from snakebiteA comparison of serum antivenom concentrations after intravenous and intramuscular administration of redback (widow) spider antivenom.Immunopharmacotherapeutic manifolds and modulation of cocaine overdose.Effective equine immunization protocol for production of potent poly-specific antisera against Calloselasma rhodostoma, Cryptelytrops albolabris and Daboia siamensis.A retrospective study of use of polyvalent anti-snake venom and risk factors for mortality from snake bite in a tertiary care setting.Population Pharmacokinetics of an Indian F(ab')2 Snake Antivenom in Patients with Russell's Viper (Daboia russelii) Bites.Inhibition of the Myotoxicity Induced by Bothrops jararacussu Venom and Isolated Phospholipases A2 by Specific Camelid Single-Domain Antibody Fragments.A single-label fluorescent derivatization method for quantitative determination of neurotoxin in vivo by capillary electrophoresis coupled with laser-induced fluorescence detection.Assessing SABU (Serum Anti Bisa Ular), the sole Indonesian antivenom: A proteomic analysis and neutralization efficacy study.Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?Antibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeutics.Venom and Purified Toxins of the Spectacled Cobra (Naja naja) from Pakistan: Insights into Toxicity and Antivenom NeutralizationIn vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibodyBungarus multicinctus multicinctus Snakebite in Taiwan.Specific Antivenom Ability in Neutralizing Hepatic and Renal Changes 24 Hours after Latrodectus dahli Envenomation.Immunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAbA randomized multicenter trial of Crotalidae polyvalent immune F(ab) antivenom for the treatment of rattlesnake envenomation in dogs.Snakebite envenoming.The development of IgY(DeltaFc) antibody based neuro toxin antivenoms and the study on their neutralization efficacies.Snakebite: When the Human Touch Becomes a Bad Touch.The Effect of a Polyvalent Antivenom on the Serum Venom Antigen Levels of Naja sputatrix (Javan Spitting Cobra) Venom in Experimentally Envenomed Rabbits.Camelid Single-Domain Antibodies (VHHs) against Crotoxin: A Basis for Developing Modular Building Blocks for the Enhancement of Treatment or Diagnosis of Crotalic Envenoming.Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without β-propiolactone, in the treatment of Bothrops asper bites in Colombia
P2860
Q21563433-C749A1D2-F8AA-4A91-98CA-E1A2A3DDD557Q26738414-BD4F2B8E-385F-42BD-8500-7E8922FEDABEQ33377062-20C67505-5AAB-4E32-AB7A-F6CE44541E84Q33612077-E9B845E8-9F86-43E3-9120-32C332213ACEQ33612097-3CE801D2-4991-4C0B-BF3B-6FF6D97581BAQ33716758-C3053295-2B75-46A6-A4DA-B8894091CB48Q33744768-BA2CB323-5914-40B9-A584-4B8143F8E959Q34224279-33B188EA-0474-4E2E-88C1-311936553F53Q34277605-C418166F-AC14-431E-8C49-ADB9BF300758Q34394906-7084DF7E-3C47-4047-85B6-5674833D67D3Q34732603-7D70DF40-7484-44AC-8E59-03EDC354DC42Q34754121-9200F0C0-CD3A-4BA0-B8F3-1349A9D2E0E3Q35180625-FBA3613A-175E-45A7-AC93-5626BD481568Q35669692-DA2B734E-E299-41F1-ABDE-D2D04142F33DQ35681038-87AD33AA-FBF9-4D11-9F50-BDB4BB1A8E88Q35974249-8AB06941-F732-4245-87FA-08BAD8F2343FQ36016823-FA32F717-4D73-4173-BF7E-8A7CEE7217D5Q36199194-960FCDC4-CF52-484D-95A9-EEA05F0E7A39Q36269593-200116B6-C31F-4914-9D72-B567B7E5A4A1Q36755847-FB335154-53FA-464D-9814-5B5AA47E9E4DQ36958571-6C0B1077-CE69-440A-910F-DCBA5B2E279EQ37033589-23A2816D-BD37-4957-A1EB-7381C90C6E0DQ38673946-CC8DAFD7-68D5-4EFE-9526-5107492450EDQ38852433-4F9D4530-EABD-45A9-BA68-74077F827C93Q42847712-2B9B8BD4-E7E0-4564-94AF-3FBAE0752532Q43667961-42E892ED-5895-4804-B905-EF032046A5ABQ46343507-7CEE7867-C1A9-4D5A-ABBE-054BE0EEE9B5Q51696604-15802254-2A53-404D-B418-11A3E3533941Q52566029-A6F14063-CEDD-4465-B8C4-242A21593D92Q53563193-0680C174-BDDA-4466-AA38-3C67B4AB9090Q55179438-4ECCADCA-82C5-4C5C-AAE3-391E4C53F371Q59290570-2B2E4E58-6D76-4F95-95C8-274BF4EFD840
P2860
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
@ast
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
@en
type
label
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
@ast
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
@en
prefLabel
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
@ast
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
@en
P50
P1476
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
@en
P304
P356
10.2165/00003088-200342080-00002
P577
2003-01-01T00:00:00Z
P5875
P6179
1049565160